The tyrosine phosphatase SHP-1 dampens murine Th17 development.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 3362360)

Published in Blood on March 20, 2012

Authors

Ileana S Mauldin1, Kenneth S Tung, Ulrike M Lorenz

Author Affiliations

1: Beirne Carter Center for Immunology Research and Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA 22908, USA.

Associated clinical trials:

Sodium Stibogluconate With Interferon Alpha-2b for Patients With Advanced Malignancies | NCT00629200

Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other Cancers | NCT00498979

Sodium Stibogluconate and Interferon in Treating Patients With Advanced Solid Tumors, Lymphoma, or Myeloma | NCT00311558

Articles citing this

Abrogation of SRC homology region 2 domain-containing phosphatase 1 in tumor-specific T cells improves efficacy of adoptive immunotherapy by enhancing the effector function and accumulation of short-lived effector T cells in vivo. J Immunol (2012) 0.91

Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T. Cancer Immunol Immunother (2015) 0.90

Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils. J Leukoc Biol (2013) 0.85

Breaking Free of Control: How Conventional T Cells Overcome Regulatory T Cell Suppression. Front Immunol (2016) 0.83

Role of protein tyrosine phosphatases in regulating the immune system: implications for chronic intestinal inflammation. Inflamm Bowel Dis (2015) 0.83

Tumor necrosis factor superfamily in innate immunity and inflammation. Cold Spring Harb Perspect Biol (2014) 0.82

Death receptor 5-targeted depletion of interleukin-23-producing macrophages, Th17, and Th1/17 associated with defective tyrosine phosphatase in mice and patients with rheumatoid arthritis. Arthritis Rheum (2013) 0.82

SHP-1 and IL-1α conspire to provoke neutrophilic dermatoses. Rare Dis (2014) 0.80

Loss of function mutations in PTPN6 promote STAT3 deregulation via JAK3 kinase in diffuse large B-cell lymphoma. Oncotarget (2015) 0.76

Targeted loss of SHP1 in murine thymocytes dampens TCR signaling late in selection. Eur J Immunol (2016) 0.75

Articles cited by this

IL-17 and Th17 Cells. Annu Rev Immunol (2009) 23.02

Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell (2009) 20.29

IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature (2007) 16.59

T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity (2007) 13.29

TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol (2007) 11.14

Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity (2006) 10.53

A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity (2001) 9.45

Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling. Nature (2010) 7.50

Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood (2008) 6.81

Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell (2011) 5.63

The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat Immunol (2011) 5.41

Th17 cell differentiation: the long and winding road. Immunity (2008) 5.40

Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol (1997) 5.38

Functional specialization of interleukin-17 family members. Immunity (2011) 5.36

IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. J Biol Chem (2007) 4.77

Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. J Immunol (2006) 4.04

Transcriptional regulation of Th17 cell differentiation. Semin Immunol (2007) 3.86

Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. Immunity (2010) 3.52

T(H)17 cells in tumour immunity and immunotherapy. Nat Rev Immunol (2010) 3.39

Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. J Immunol (2008) 3.11

Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology (2009) 2.92

Commensal gut flora drives the expansion of proinflammatory CD4 T cells in the colonic lamina propria under normal and inflammatory conditions. J Immunol (2008) 2.50

Th17 cells: a new fate for differentiating helper T cells. Immunol Res (2008) 2.45

Transcriptional regulatory networks in Th17 cell differentiation. Curr Opin Immunol (2009) 2.12

Human TH17 cells are long-lived effector memory cells. Sci Transl Med (2011) 1.99

Recent advances in the IL-17 cytokine family. Curr Opin Immunol (2011) 1.86

The many faces of Th17 cells. Curr Opin Immunol (2011) 1.84

Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma. Blood (2010) 1.79

SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels. Immunol Rev (2009) 1.78

Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines. J Immunol (2001) 1.73

A nonredundant role for the adapter protein Shc in thymic T cell development. Nat Immunol (2002) 1.70

Identification of major binding proteins and substrates for the SH2-containing protein tyrosine phosphatase SHP-1 in macrophages. Mol Cell Biol (1998) 1.61

Interleukin-17-producing T helper cells in autoimmunity. Autoimmun Rev (2010) 1.22

Unlike Th1, Th17 cells mediate sustained autoimmune inflammation and are highly resistant to restimulation-induced cell death. J Immunol (2009) 1.19

The tyrosine phosphatase SHP-1 influences thymocyte selection by setting TCR signaling thresholds. Int Immunol (1999) 1.12

T cell factor-1 negatively regulates expression of IL-17 family of cytokines and protects mice from experimental autoimmune encephalomyelitis. J Immunol (2011) 1.08

Th17 and cancer: friends or foes? Blood (2008) 1.02

Deficiency of the Src homology region 2 domain-containing phosphatase 1 (SHP-1) causes enrichment of CD4+CD25+ regulatory T cells. J Immunol (2005) 0.99

The protein tyrosine phosphatase SHP-1 modulates the suppressive activity of regulatory T cells. J Immunol (2010) 0.92

Induction of lamina propria Th17 cells by intestinal commensal bacteria. Vaccine (2010) 0.90

Articles by these authors

Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation. J Exp Med (2010) 2.44

Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells. Blood (2012) 1.95

BAFF regulates follicular helper t cells and affects their accumulation and interferon-γ production in autoimmunity. Arthritis Rheumatol (2015) 1.45

Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritis. J Am Soc Nephrol (2012) 1.40

ePAD, an oocyte and early embryo-abundant peptidylarginine deiminase-like protein that localizes to egg cytoplasmic sheets. Dev Biol (2003) 1.37

Characterizing emergent properties of immunological systems with multi-cellular rule-based computational modeling. Trends Immunol (2008) 1.06

B cell maturation antigen deficiency exacerbates lymphoproliferation and autoimmunity in murine lupus. J Immunol (2011) 0.96

Impaired natural killer cell self-education and "missing-self" responses in Ly49-deficient mice. Blood (2012) 0.96

Isocitrate ameliorates anemia by suppressing the erythroid iron restriction response. J Clin Invest (2013) 0.85

Natural killer cells regulate murine cytomegalovirus-induced sialadenitis and salivary gland disease. J Virol (2011) 0.83

Viral IL-10-mediated immune regulation in pancreatic islet transplantation. Mol Ther (2005) 0.79

Pathogenesis of gastritis in ileitis-prone SAMP1/Yit mice. Keio J Med (2011) 0.75